Key result
Childhood MASLD is linked to ~53% higher HOMA-IR scores versus healthy controls, highlighting diagnostic potential.
Why the study?
Practical biochemical indices and easy biomarkers were needed for the early diagnosis of suspected MASLD and to help clinicians recognize the disease in obese children.
Do biochemical indices accurately diagnose metabolic dysfunction-associated steatotic liver disease in children?
Case-Control (n=160)
No
Do biochemical indices accurately diagnose metabolic dysfunction-associated steatotic liver disease in children?
Absolute Event Rate: 5.612% vs 3.666%
p-value: p=<0.001
Biochemical indices such as HOMA-IR and lipid ratios can serve as practical biomarkers for the early diagnosis of metabolic dysfunction-associated steatotic liver disease and insulin resistance in children.
Purpose: The objectives of the present study were to develop biochemical indices as a more practical way for the early diagnosis of cases with suspected metabolic dysfunction-assosiated steatotic liver disease (MASLD) and to develop easy biomarkers to enable clinicians to recognize MASLD in obese children. Materials and Methods: A total of 90 patients who had MASLD and 70 healthy volunteering children between the ages of 6-18 who were diagnosed with reference to the ESPGHAN 2012 Guideline between January 2020 and March 2023 were included. Age, gender, Anthropometric measurements and biochemical analysis were determined. Some Biochemical ratios such as HOMA-IR, HOMA-β, FGIR, QUICKI, AIP etc were calculated. Results: There were 40 (44.4%) girls and 50 (55.6%) boys in the patient group.A positive correlation was found between AST, GGT, TSH, LDL, TG, total cholesterol, HDL, FAS, insulin, HOMA-IR, HOMA-β, QUICKI score, FGIR, MHR, LHR, LKR, THR ALT/AST ratios and Systemic Immun Inflammatory Index values in the analysis. The ROC analysis results of the HOMA-IR value was taken as 2.94, the specificity of the diagnostic value was found to be 52.20% and the sensitivity was 80.0%. Conclusion: MASLD has an increasing trend today.Based on the design of the present study, it was concluded that almost all of the biochemical parameters and biomarkers obtained are among the most accurate and useful indices to determine MASLD and IR and predict complications.
No takes yet. Share an insight, caveat, or question.
Gümüş et al. (2023) conducted a case-control in Metabolic dysfunction-associated steatotic liver disease (MASLD) (n=160). Metabolic dysfunction-associated steatotic liver disease vs. Healthy controls was evaluated on HOMA-IR score (p=<0.001). Children with metabolic dysfunction-associated steatotic liver disease had significantly higher HOMA-IR scores compared to healthy controls (5.612 vs 3.666, p<0.001), indicating its potential as a diagnostic biomarker.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: